Insider Transactions in Q1 2025 at Biocryst Pharmaceuticals Inc (BCRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2025
|
Helen M. Thackray Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-1.96%
|
$52,675
$7.5 P/Share
|
|
Feb 28
2025
|
Vincent Milano Director |
BUY
Grant, award, or other acquisition
|
Direct |
653
+0.84%
|
$5,224
$8.61 P/Share
|